Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICH Seeks To Resolve Impasse Over Q12 Legal Review This Week

Executive Summary

It remains uncertain whether a legal review by the European Commission that since June has delayed public consultation of draft ICH Q12 post-approval changes guideline can be resolved during this week's ICH meeting in Geneva.

Advertisement

Related Content

Japan Commits to Comparability Protocols as ICH Q12 Takes Shape
FDA Would Establish Conditions For Swift Manufacturing Changes
ICH Q12 to Foster Post-Approval Change Management
Industry’s ‘Regulatory Commitments’ Concept Draws FDA’s Interest
The Post-Approval Challenge of Global Regulatory Complexity

Topics

Advertisement
UsernamePublicRestriction

Register

PS121947

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel